D-0459-2017 Class II Terminated

Recalled by VistaPharm, Inc. — Largo, FL

FDA drug recall D-0459-2017 was initiated by VistaPharm, Inc. on Jan 18, 2017 and is designated Class II. Reason for recall: CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia. The recall status is terminated (terminated Aug 26, 2021). Affected quantity: 3,496 unit dose cups.

Recall Details

Product Type
Drugs
Report Date
Feb 8, 2017
Initiation Date
Jan 18, 2017
Termination Date
Aug 26, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,496 unit dose cups

Product Description

Metoclopramide Oral Solution, USP 10 mg/ 10 mL, 50 unit dose cups of 10 mL per case, Rx only, Manufactured by VistaPharm, Largo, FL 33771, NDC No. 66689-031-50.

Reason for Recall

CGMP Deviations: Purified water used to manufacture the drug products may have been contaminated with Burkholderia cepacia.

Distribution Pattern

Nationwide

Code Information

Lot No. 428700 (Exp. 11/17), 409500 (Exp.06/17)

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0459-2017
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0459-2017. Report a data issue: hello@regdatalab.com.